Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: ANAVEX2-73 for Treatment of Early Alzheimer's Disease [Phase 2, Phase 3]
Clinical trials for ANAVEX2-73 in early Alzheimer's disease completed Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease [Phase 4]
A Phase 4 trial update assessing the efficacy and safety of memantine combined with sodium oligomannate in patients with moderate to severe …
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer's Disease [NA]
A completed clinical trial investigating the impact of Photobiomodulation on biomarkers of Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Benfotiamine in Alzheimer's Disease: A Pilot Study [Phase 2]
A Phase 2 pilot study assessing benfotiamine in Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: A Study of Gantenerumab in Participants With Mild Alzheimer Disease [Phase 3]
Phase 3 clinical trial update for gantenerumab in mild Alzheimer's disease completed; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]
Open-label study of isotretinoin in mild to moderate Alzheimer's disease was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: The Cognition and Flow Study [NA]
Clinical trial update for the Cognition and Flow Study (NCT03656107) has been terminated with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies [Phase 4]
Phase 4 clinical trial investigating nasal brushing samples from olfactory mucosa for diagnosing encephalopathies.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease [Phase 4]
Phase 4 clinical trial investigating nighttime agitation and restless legs syndrome in people with Alzheimer's disease is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating a computerized olfactory training program for cognitive decline in early Alzheimer's disease and mild cogn…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease [Phase 4]
Phase 4 trial evaluating whether regular cognitive exercises contribute to treatment effects in Alzheimer's disease patients.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability [Phase 2]
Phase 2 trial update for levetiracetam in Alzheimer's disease-associated network hyperexcitability completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: In-Home Technology for Dementia Caregivers [NA]
A completed clinical trial from UC Berkeley examined in-home technology for dementia caregivers, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment [NA]
Clinical trial evaluating in-home technology support for caregivers of people with dementia and mild cognitive impairment has completed with…
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD) [Phase 2]
Phase 2 study evaluating Lecozotan SR in mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial results for NCP-5 in mild cognitive impairment due to Alzheimer’s disease or mild dementia of the Alzheimer’s type have been c…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Blood Brain Barrier Opening in Alzheimer' Disease [Phase 1, Phase 2]
Phase 1/2 trial exploring blood-brain barrier opening in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for MW150, a stress kinase inhibitor, in patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating semorinemab in prodromal to mild Alzheimer's disease was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-03-03Clinical Trial Update: tACS for Amyloid-β Reduction in Alzheimer's Disease [NA]
A completed clinical trial evaluating transcranial alternating current stimulation (tACS) for reduction of amyloid-β in Alzheimer's disease;…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) [Phase 2]
This document reports the completion and posting of results from the Phase 2 TRAILBLAZER-ALZ trial evaluating LY3002813 in adults with early…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Risk Reduction for Alzheimer's Disease [Phase 2, Phase 3]
Phase 2/3 clinical trial update on risk reduction for Alzheimer's disease in cognitively normal older adults, including those with hypertens…
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: SCI-110 for Alzheimer Disease and Agitation [Phase 2]
Phase 2 clinical trial update for SCI-110 in Alzheimer disease and agitation is in early stages with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Longitudinal Study of Brain Amyloid imaGing in MEMENTO [Phase 3]
Phase 3 longitudinal study update on brain amyloid imaging in Alzheimer's disease and related disorders (NCT02164643) completed.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Acupuncture to Reduce Anxiety in Alzheimer's Disease (AD) and AD Related Dementias [NA]
A terminated clinical trial investigating acupuncture to reduce anxiety in Alzheimer's disease and related dementias; results posted in 2022…